International Models of Care that Address the Growing Diabetes Prevalence in Developing Countries

Singh, Kavita; Ranjani, Harish; Rhodes, Elizabeth; Weber, Mary Beth

doi:10.1007/s11892-016-0768-9

Cited by 7 publications

(2 citation statements)

References 76 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In both developing and developed countries, an increasing prevalence of risk factors, such as hypertension and diabetes, may also be playing a role in the increased incidence of kidney cancer. Three‐quarters of the 415 million people living with diabetes worldwide live in developing countries . While the prevalence of hypertension is only 23% in developing nations compared with 37% in the developed world, the absolute number of patients affected by hypertension is considerably higher in developing nations and continues to rise as increased globalization leads to increased rates of hypertension and diabetes and improvement in infectious diseases lead to longer life expectancy .…”

Section: Discussionmentioning

confidence: 99%

Association of Human Development Index with global bladder, kidney, prostate and testis cancer incidence and mortality

2017

View full text Add to dashboard Cite

ObjectivesTo describe contemporary worldwide age-standardized incidence and mortality rates for bladder, kidney, prostate and testis cancer and their association with development. Materials and MethodsWe obtained gender-specific, age-standardized incidence and mortality rates for 184 countries and 16 major world regions from the GLOBOCAN 2012 database. We compared the mortality-to-incidence ratios (MIRs) at national and regional levels in males and females, and assessed the association with socio-economic development using the 2014 United Nations Human Development Index (HDI). ResultsAge-standardized incidence rates were 2.9 (bladder) to 7.4 (testis) times higher for genitourinary malignancies in more developed countries compared with less developed countries. Age-standardized mortality rates were 1.5-2.2 times higher in more vs less developed countries for prostate, bladder and kidney cancer, with no variation in mortality rates observed in testis cancer. There was a strong inverse relationship between HDI and MIR in testis (regression coefficient 1.65, R 2 = 0.78), prostate (regression coefficient À1.56, R 2 = 0.85), kidney (regression coefficient À1.34, R 2 = 0.74), and bladder cancer (regression coefficient À1.01, R 2 = 0.80). ConclusionWhile incidence and mortality rates for genitourinary cancers vary widely throughout the world, the MIR is highest in less developed countries for all four major genitourinary malignancies. Further research is needed to understand whether differences in comorbidities, exposures, time to diagnosis, access to healthcare, diagnostic techniques or treatment options explain the observed inequalities in genitourinary cancer outcomes.

show abstract

Section: Discussionmentioning

confidence: 99%

Association of Human Development Index with global bladder, kidney, prostate and testis cancer incidence and mortality

2017

View full text Add to dashboard Cite

show abstract

“…The feedback from the Masterclass series highlights the need for multidisciplinary cooperation in optimizing HCV care. Data from the literature indicate the success of multidisciplinary models in enhancing treatment outcomes in the field of diabetes, 9 HIV/HCV comorbidiy 10 and oncology 11 . The pivotal role of a liaison nurse in the HCV cascade of care was highlighted in the feedback forms from the Masterclasses, and this is supported in previous research outlining the central role of liaison nurses in HCV treatment to enhance patient access to treatment, and improve adherence rates to treatment 12 .…”

Section: Discussionmentioning

confidence: 79%

Integrating primary and secondary care to optimize hepatitis C treatment: development and evaluation of a multidisciplinary educational Masterclass series

McCombe

Almaazmi

Cullen

et al. 2019

Journal of Antimicrobial Chemotherapy

View full text Add to dashboard Cite

BackgroundIt is increasingly being recognized that the elimination of HCV requires a multidisciplinary approach and effective cooperation between primary and secondary care.ObjectivesAs part of a project (HepCare Europe) to integrate primary and secondary care for patients at risk of or infected with HCV, we developed a multidisciplinary educational Masterclass series for healthcare professionals (HCPs) working in primary care in Dublin and Bucharest. This article aims to describe and evaluate the series and examine how this model might be implemented into practice.MethodsGPs and other HCPs working in primary care, addiction treatment services and NGOs were invited to eight 1 day symposia (HCV Masterclass series), examining the burden and management of HCV in key populations. Peer-support sessions were also conducted, to give people affected by HCV and community-based organizations working with those directly affected, an update on the latest developments in HCV treatment.ResultsOne hundred percent of participants ‘strongly agreed’ or ‘agreed’ that the Masterclass helped them to appreciate the role of integrated services in ‘the management of patients with HCV’. One hundred percent of participants indicated the importance of a ‘designated nurse to liaise with hospital services’. An improvement of knowledge regarding HCV management of patients with high-risk behaviour was registered at the end of the course.ConclusionsIntegrated approaches to healthcare and improving the knowledge of HCPs and patients of the latest developments in HCV treatment are very important strategies that can enhance the HCV care pathway and treatment outcomes.

show abstract

Efficacy of a telephone-based intervention among patients with type-2 diabetes; a randomized controlled trial in pharmacy practice

et al. 2018

View full text Add to dashboard Cite

Background Pharmacists' interventions to improve outcomes of diabetes management have been promising. However, evidence on using telephone-based interventions in pharmacy practice are limited, particularly in developing countries. Objective To evaluate the efficacy of a telephone-based intervention to improve care and clinical outcomes in type-2 diabetes. Setting A referral community pharmacy and drug information center. Method We conducted a two-armed randomized controlled trial on 100 patients with type-2 diabetes. The intervention consisted of 16 telephone calls in 3 month by a trained pharmacist working in an academic drug information center, while the control group received usual care. Before random allocation, patients attended a live education session delivered by pharmacists to learn the basics of diabetes care and to confirm the eligibility criteria. Assessments were performed at baseline, month-3 (after intervention), and month-9 (follow-up). Main outcome measure Hemoglobin A1c (HbA1c). Results Eighty four patient completed the trial. Baseline variables were comparable between the two groups and the baseline value of hemoglobin A1c was 8.00 ± 1.44 in the study population. HbA1c was significantly improved in both groups at month-3 (6.97 ± 1.41 vs. 7.09 ± 1.78) and remained steady at month-9 (6.96 ± 1.44 vs. 7.26 ± 1.85). Lipid profile showed small improvements in the intervention group but was not significant. The adherence score and self-care score improvement was significantly higher in the intervention group at month-3 and were maintained at month-9. Conclusion Medication adherence and self-care significantly improved in the telephone-based intervention group. However, the improvement of clinical outcomes might have been diluted due to the live diabetes education session.

show abstract

International Models of Care that Address the Growing Diabetes Prevalence in Developing Countries

Cited by 7 publications

References 76 publications

Association of Human Development Index with global bladder, kidney, prostate and testis cancer incidence and mortality

Association of Human Development Index with global bladder, kidney, prostate and testis cancer incidence and mortality

Integrating primary and secondary care to optimize hepatitis C treatment: development and evaluation of a multidisciplinary educational Masterclass series

Efficacy of a telephone-based intervention among patients with type-2 diabetes; a randomized controlled trial in pharmacy practice

Contact Info

Product

Resources

About